Mosaic ImmunoEngineering (CPMV) Market Capitalization (2013 - 2026)

Mosaic ImmunoEngineering has reported Market Capitalization for 14 years, with the latest figure at $5.4 million in Q1 2026.

• On a quarterly basis, Market Capitalization fell 3.85% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 3.85% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 55.71% from the prior year.
• Market Capitalization was $5.4 million for Q1 2026 at Mosaic ImmunoEngineering, up from $2.2 million in the prior quarter.
• The five-year high for Market Capitalization was $13.0 million in Q2 2022, with the low at $2.2 million in Q4 2025.
• Average Market Capitalization over 5 years is $5.5 million, with a median of $5.4 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization plunged 72.49% in 2022, then jumped 143.75% in 2025.
• Over 5 years, Market Capitalization stood at $7.2 million in 2022, then tumbled by 39.39% to $4.3 million in 2023, then increased by 16.67% to $5.1 million in 2024, then plunged by 55.71% to $2.2 million in 2025, then jumped by 141.94% to $5.4 million in 2026.
• The last three Market Capitalization figures came in at $5.4 million (Q1 2026), $2.2 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.